D-0071-2019 Class II Terminated

Recalled by Product Quest Manufacturing LLC — Daytona Beach, FL

FDA drug recall D-0071-2019 was initiated by Product Quest Manufacturing LLC on Aug 3, 2018 and is designated Class II. Reason for recall: Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus. The recall status is terminated (terminated Mar 30, 2021). Affected quantity: 25,596 sticks.

Recall Details

Product Type
Drugs
Report Date
Oct 24, 2018
Initiation Date
Aug 3, 2018
Termination Date
Mar 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25,596 sticks

Product Description

CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate 5%, octocrylene 10%, Net Wt. 0.15 oz. (4.25 g) stick, CeraVe LLC., New York, NY 10001, UPC 3 01872 49201 7.

Reason for Recall

Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.

Distribution Pattern

Nationwide in the USA

Code Information

Lot: PSP85W/172792H

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0071-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.